Starpharma Holdings Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Starpharma Holdings Limited
Plus recent deals involving AbbVie/Caribou, Sanofi/i2O, Merck & Co./Starpharma, Protalix/SarcoMed, Targovax/Papyrus, Medivir/Ubiquigent, Eton/Azurity
Australian sexual health specialist Starpharma launches its innovative, antibiotic-free Viva Gel BV bacterial vaginosis treatment in the UK.
Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.
Sanofi returns two partnered assets to Voyager, further unraveling 2015 deal. Celgene drops Mereo cancer candidate ahead of merger with Bristol, while Ultragenyx and Arcturus expand their joint rare disease efforts.
- Drug Delivery
- Nanotechnology, Chips, etc.
- Other Names / Subsidiaries
- Dendritic Nanotechnologies Inc.